The trajectory of companies tied to blockbuster drugs like Viagra presents a complex investment landscape . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the loss of exclusivity in key markets has introduced significant uncertainty . Investors are now facing the impact of generic compe